Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jun 29, 2023
TickeronGET DAILY SIGNALS

Boost Profits with Sector Rotation Strategy: Swing Trader Generates 7.12% for IDXX

Swing Trader's Sector Rotation Strategy Generates 7.12% for IDXX

Swing trading is a popular trading strategy that aims to capture short-term price movements in the market. By utilizing a combination of technical analysis (TA) and fundamental analysis (FA), swing traders identify opportunities for profit within specific sectors. In the case of IDXX, a leading company in the healthcare sector, a swing trader employing the sector rotation strategy has generated an impressive strong performance. Furthermore, the momentum indicator for IDXX has turned positive, indicating the emergence of a new upward trend. This article explores the effectiveness of the sector rotation strategy and highlights the positive momentum surrounding IDXX.

Analyzing the Sector Rotation Strategy:

The sector rotation strategy is based on the premise that different sectors of the economy perform better during specific phases of the business cycle. By identifying these cycles and allocating investments accordingly, swing traders can potentially benefit from the upward movements within each sector. In this case, the swing trader successfully applied this strategy to IDXX, yielding a notable strong performance.

The healthcare sector, where IDXX operates, has shown resilience and growth potential, especially in recent times. Factors such as technological advancements, increasing demand for healthcare services, and a focus on innovation have contributed to the sector's overall positive performance. By strategically timing their trades and focusing on sectors with favorable conditions, swing traders can capitalize on these opportunities.

Positive Momentum for IDXX:

In addition to the sector rotation strategy, swing traders often rely on technical indicators to validate their trading decisions. One such indicator is the momentum indicator, which measures the rate of change in a stock's price. The recent positive turn in the momentum indicator for IDXX indicates a new upward trend in the stock's price.

This positive momentum suggests that IDXX may experience continued price appreciation in the near future. Swing traders who have identified this upward trend early on can potentially benefit from further gains as the stock's price continues to rise.

The sector rotation strategy employed by swing traders has proven fruitful for IDXX, generating a commendable strong performance. Furthermore, the positive turn in the momentum indicator signals the emergence of a new upward trend for IDXX's stock price. The combination of sector rotation and technical analysis provides swing traders with valuable insights and opportunities for profit.

It is important to note that every investment strategy carries inherent risks, and individuals should carefully evaluate their financial goals and risk tolerance before implementing any trading strategy. Nevertheless, the sector rotation strategy, when applied diligently and supported by technical indicators, can offer potential rewards for savvy swing traders.

Related Ticker: IDXX

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


IDXX in upward trend: 10-day moving average moved above 50-day moving average on October 21, 2026

The 10-day moving average for IDXX crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on IDXX as a result. In 55 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.

IDXX moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDXX advanced for three days, in 177 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDXX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

IDXX broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating fairly steady price growth. IDXX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (32.812) is normal, around the industry mean (65.876). P/E Ratio (46.935) is within average values for comparable stocks, (3.542). Projected Growth (PEG Ratio) (2.894) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (9.042) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDXX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 21.35B. The market cap for tickers in the group ranges from 27 to 4.39T. MKYSF holds the highest valuation in this group at 4.39T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 42%. CDNA experienced the highest price growth at 24%, while ADVB experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 34%. For the same stocks of the Industry, the average monthly volume growth was 23% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 52
Price Growth Rating: 43
SMR Rating: 78
Profit Risk Rating: 85
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
IDXX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of animal health products

Industry MedicalSpecialties

Industry
Medical Specialties
Address
One IDEXX Drive
Phone
+1 207 556-0300
Employees
11000
Web
https://www.idexx.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.